JAK-IN-17
JAK-IN-17 is a potent inhibitor of JAK. JAK-IN-17 is useful for the research of multiple diseases, particularly ocular, skin, and respiratory diseases (extracted from patent WO2021185305A1, compound 9-1) [1].
Product Specifications
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak-in-17.html
Solubility
10 mM in DMSO
Smiles
CC([C@@H]([C@H](C(O)=O)O)O)=O.CCC1=CC(O)=C(C=C1C2=CC(F)=C3C(NN=C3C4=NC5=C(N4)CCN(C5)C(CN6CCO[C@H](C6)C)=O)=C2)F
Molecular Formula
C33H38F2N6O8
Molecular Weight
684.69
References & Citations
[1]Zhang Chen, et al. An indazole derivative and its application in medicine. Patent WO2021185305A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2858834 100 µL
Phospho-NFKB p65 (Thr435) Rabbit pAb, BF700 conjugated
Sign In for Pricing
View Details SIPH908Mu01-01 10 µg
Recombinant Huntingtin Associated Protein 1 (HAP1)
Sign In for Pricing
View Details SIPH908Mu01-02 50 µg
Recombinant Huntingtin Associated Protein 1 (HAP1)
Sign In for Pricing
View Details SIPH908Mu01-03 200 µg
Recombinant Huntingtin Associated Protein 1 (HAP1)
Sign In for Pricing
View Details SIPH908Mu01-04 1 mg
Recombinant Huntingtin Associated Protein 1 (HAP1)
Sign In for Pricing
View Details